Rapid acceleration of diagnostics (radx) clinical evaluation services

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75N92022D00010
Awardee
Awarding agency
Task orders
6 $52,612,711 obligated

Award facts

Opportunity
  • 75N92022R0101 Solicitation number
Combined order value
  • $52,612,711 Current, with exercised options
  • $53,073,563 Potential, with all options
Last date to order 100% complete
IDV ceiling 91% used
$58,080,239.76
Award type
Single award
Who can order
Only the awarding agency
Funding agency
National Institute of Biomedical Imaging and Bioenginering National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
1 offer Only One Source
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Biomedical Imaging and Bioengineering awarded a single-award indefinite delivery contract to National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell) for $58,080,239.76 on June 13, 2022, with ultimate completion on June 12, 2023. No set-aside was used.

The IDIQ procures Rapid Acceleration of Diagnostics (RADx) clinical evaluation services, including clinical testing and evaluation of diagnostic devices, platforms, and technologies developed under the RADx initiative. Place of performance is Hadley, Massachusetts (Venturewell's headquarters) with subordinate performance locations in Bethesda, Maryland.

The National Heart Lung and Blood Institute issued multiple delivery orders under this IDIQ. The most recent order, issued June 1, 2023, valued at $21.04 million with completion by June 30, 2026, supports clinical evaluation services for RADx diagnostic technologies. FY2024 activity invoiced $8.1 million and FY2025 invoiced $3.9 million, with rates of $2,896.15 per hour and $4,936.47 per hour respectively. Earlier delivery orders include a $12.25 million order issued February 15, 2023 for clinical evaluation of RADx projects 13091, 13454, 16345, 16404, and 16491 (completion May 31, 2024); a $7.73 million order issued November 15, 2022 for T2T COVID-19 antigen test evaluation (completion August 30, 2024); a $2.93 million order issued December 29, 2022 for RADx projects 6818 and 13379 (completion May 31, 2024); a $2.10 million order issued September 15, 2022 (completion June 20, 2024); and a $7.02 million order issued June 16, 2022 (completion June 15, 2023). All delivery orders are firm fixed-price with no set-aside designation.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00001 $0
Other Administrative Action P00002 · Nibib - rapid acceleration of diagnostics (radx) clinical evaluation services $0
Original award $0

Quick answers

Who was awarded contract 75N92022D00010?

75N92022D00010 was awarded to National Collegiate Inventors & Innovators Alliance, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on June 13, 2022.

How much is contract 75N92022D00010 worth?

Orders under 75N92022D00010 have obligated $52,612,711. Their combined potential value, with all options, is $53,073,563. 75N92022D00010's own ceiling is $58,080,240.

How many orders have been placed under contract 75N92022D00010?

6 orders have been placed under 75N92022D00010, the latest on June 1, 2023.

Which agency awarded contract 75N92022D00010?

National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92022D00010, with funding from National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health).

Who can order from contract 75N92022D00010?

75N92022D00010 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N92022D00010 competed?

The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV